PHILADELPHIA, Feb. 22, 2012 (GLOBE NEWSWIRE) -- When Vascular Magnetics raised $7 million in Series A financing this month, it demonstrated more than the potential of the start-up company’s proprietary, magnetically targeted drug delivery system for the treatment of peripheral artery disease (PAD). It also proved the power of Philadelphia’s entrepreneurial ecosystem.
